On June 8th and 9th, the partners of the HAPPY PATIENT project gathered in Copenhagen to assess the progress of this project, which started in 2021 and will run until the end of this year, 2023. Around thirty professionals from different parts of Europe gathered at the University of Copenhagen...
Etiqueta: AMR
Professor Lars Bjerrum highlights the role of the IDIAPJGol in European research projects
Last week, the Research Institute in Primary Healthcare IDIAPJGol and the Catalan Institute of Health (ICS) presented their Annual Awards for "Research in Primary Health Care IDIAPJGol-ICS". A total of 23 researchers were awarded in different categories.
WHO warns of too few new drugs for deadly superbugs
The WHO has called on governments and pharmaceutical companies to invest in research and development of new antibiotics and has also recommended that antibiotics be used more judiciously to prevent the emergence of drug-resistant bacteria.
AMR: An ever-growing problem
The problem of antimicrobial resistance (AMR) is ever-growing and resolving it is high on the agenda of many international organizations, including the European Commission. They have adopted an action plan against AMR of which the main goals are to make the EU a best practice region and to boost research,...
WHO IS WHO in HAPPY PATIENT: University of Groningen – RUG
The Department of PharmacoTherapy -Epidemiology and Economics of the University of Groningen (The Netherlands) is responsible for WP6 which is leading the Audit cycles in community pharmacies and adapting the APO Templates to pharmacies in the Target Countries. The members who are participating in the HAPPY PATIENT project come from very different...